CNS Pharmaceuticals Inc
NASDAQ:CNSP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
CNS Pharmaceuticals Inc
NASDAQ:CNSP
|
US |
|
Anup Engineering Ltd
NSE:ANUP
|
IN |
|
R
|
Rockfire Resources PLC
F:P2P
|
UK |
|
S
|
SEI Investments Co
F:SI3
|
US |
|
Danske Bank A/S
F:DSN
|
DK |
|
Phoenix Mecano AG
SIX:PM
|
CH |
|
Stellantis NV
MIL:STLAM
|
NL |
|
Venus Concept Inc
NASDAQ:VERO
|
CA |
|
O
|
Ooh!Media Ltd
OTC:OMLAF
|
AU |
|
Vidrala SA
MAD:VID
|
ES |
|
A
|
Asetek A/S
SWB:A31
|
DK |
|
C
|
Centamin PLC
OTC:CELTF
|
JE |
|
G
|
Gorman-Rupp Co
F:GO4
|
US |
|
Quantum Graphite Ltd
ASX:QGL
|
AU |
|
B
|
Brightview Holdings Inc
F:7BV
|
US |
|
A
|
Airtel Africa PLC
OTC:AAFRF
|
UK |
|
DraftKings Inc
F:IK1
|
US |
|
Luceco PLC
F:2LC
|
UK |
|
F
|
FibroGen Inc
F:1FG
|
US |
|
Storagevault Canada Inc
F:0SV
|
CA |
|
S
|
Sealed Air Corp
F:SDA
|
US |
|
M
|
Murphy Oil Corp
DUS:MUQ
|
US |
|
Bel Fuse Inc
NASDAQ:BELFA
|
US |
|
A
|
Aflac Inc
XMUN:AFL
|
US |
Wall St Price Targets
CNSP Price Targets Summary
CNS Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
CNSP is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CNSP's stock price target?
Price Target
10.2
USD
According to Wall Street analysts, the average 1-year price target for
CNSP is 10.2 USD with a low forecast of 10.1 USD and a high forecast of 10.5 USD.